Go Deep
Kronox Lab Sciences Limited
Kronox Lab Sciences Limited Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Oct 2026 | 21,951 | 26.4 | 6.57 | 0.01 | 205.57 |
| Oct 2026 | 21,401 | 25.7 | 6.33 | 0.01 | 198.28 |
Kronox Lab Sciences Limited Quarterly Results
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|---|
| Revenue | 283,860,000.0 | 261,263,000.0 | 252,740,000.0 | 255,332,000.0 |
| Net Profit | 73,030,000.0 | 80,021,000.0 | 65,890,000.0 | 66,762,000.0 |
| EPS | 2.0 | 2.2 | 1.8 | 1.8 |
Kronox Lab Sciences Limited Revenue & Profit: Last 5 Years
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
| Revenue | 1,012,200,000.0 | 1,001,940,000.0 | 898,624,000.0 | 955,780,000.0 | — |
| Net Profit | 276,600,000.0 | 254,670,000.0 | 213,513,000.0 | 166,170,000.0 | — |
| EPS | 7.5 | 6.9 | 5.8 | 4.5 | — |
Kronox Lab Sciences Limited Balance Sheet
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
| Total Assets | 1,275,230,000.0 | 988,260,000.0 | 739,942,000.0 | 540,340,000.0 | — |
| Total Liabilities | 113,960,000.0 | 87,210,000.0 | 76,892,000.0 | 93,550,000.0 | — |
| Total Equity | 1,161,270,000.0 | 901,050,000.0 | 663,050,000.0 | 446,790,000.0 | — |
Owes vs Owns
Kronox Lab Sciences Limited owed ₹0.09 for every ₹1 it owned in Mar 2026, down from ₹0.17 in Mar 2023.
| Period | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Owes vs Owns | 0.09× | 0.09× | 0.10× | 0.17× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
Kronox Lab Sciences Limited Assets & Liabilities Breakdown (₹ Cr)
What it owns — Mar 2026
Cash & short-term investments 38.2%Receivables 16.6%Inventory 6.6%Fixed assets (tangible) 23.2%Long-term investments 14.6%Other assets 0.8%
How it's funded — Mar 2026
Long-term debt 0.8%Payables 5.2%Other liabilities 2.5%Shareholders' equity 91.1%
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Assets | ||||
| Cash & short-term investments | 48.7 | 36.7 | 14.9 | 5.6 |
| Receivables | 21.2 | 19.9 | 17.6 | 18.6 |
| Inventory | 8.4 | 6.4 | 9.3 | 9.2 |
| Fixed assets (tangible) | 29.6 | 28.6 | 26.9 | 15.9 |
| Intangible assets | 0.0 | 0.0 | 0.0 | 0.0 |
| Long-term investments | 18.6 | 6.4 | 0.0 | 3.5 |
| Other assets | 1.1 | 0.9 | 5.3 | 1.2 |
| Liabilities & equity | ||||
| Short-term debt | 0.6 | 0.0 | 0.0 | 0.0 |
| Long-term debt | 1.0 | 0.0 | 0.0 | 0.0 |
| Payables | 6.6 | 7.3 | 6.4 | 7.8 |
| Other liabilities | 3.2 | 1.4 | 1.3 | 1.5 |
| Shareholders' equity | 116.1 | 90.1 | 66.3 | 44.7 |
| Net tangible assets | 116.1 | 90.1 | 66.3 | 44.7 |
Kronox Lab Sciences Limited Cash Flow
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
| Operating Activities | 238,920,000.0 | 306,970,000.0 | 174,151,000.0 | 196,650,000.0 | — |
| Investing Activities | -238,200,000.0 | -283,940,000.0 | -173,122,000.0 | -55,170,000.0 | — |
| Financing Activities | -3,620,000.0 | -18,540,000.0 | 0.0 | -133,960,000.0 | — |